Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?

Patients with blood disorders (including leukaemia, platelet function disorders and coagulation factor deficiencies) or acute bleeding receive blood-derived products, such as red blood cells, platelet concentrates and plasma-derived products. Although the risk of pathogen contamination of blood prod...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ann Hematol
Main Authors: Di Minno, Giovanni, Navarro, David, Perno, Carlo Federico, Canaro, Mariana, Gürtler, Lutz, Ironside, James W., Eichler, Hermann, Tiede, Andreas
Format: Artigo
Sprog:Inglês
Udgivet: Springer Berlin Heidelberg 2017
Fag:
Review Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5486800/
https://ncbi.nlm.nih.gov/pubmed/28624906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-017-3028-4
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker